Novo Nordisk Q3 results: Ozempic maker’s profit falls 27%; cuts 9,000 jobs
Novo Nordisk, maker of Ozempic and Wegovy, lowered its 2025 sales outlook for the fourth time, citing slower growth in diabetes and obesity treatments. The ...
Latest Post
Relief for US homebuyers as mortgage rates dip to 6.01%, lowest level in over 3 years
No valid response from Gemini.
‘Air India fleet reliability has improved’: CEO Campbell Wilson highlights upgrades
No valid response from Gemini.
AI can’t be regulated by single instrument: Swiss president Guy Parmelin
Swiss President Guy Parmelin advocates for a multi-faceted AI governance framework, emphasizing societal norms alongside legal and technical standards. He also discusses Switzerland’s commitment to ...
Silver jumps to Rs 2.64 lakh/kg; gold climbs past Rs 1.58 lakh/10g as safe-haven demand strengthens
No valid response from Gemini.
US stocks today: Wall Street slips as oil prices rise on Iran tensions
No valid response from Gemini.